LY4337713
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 31, 2025
FiREBOLT: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
(clinicaltrials.gov)
- P1 | N=241 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Platinum resistant • Biliary Cancer • Breast Cancer • Cholangiocarcinoma • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Ovarian Cancer • Pancreatic Cancer • Solid Tumor
October 16, 2025
FiREBOLT: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
(clinicaltrials.gov)
- P1 | N=241 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Biliary Cancer • Breast Cancer • Cholangiocarcinoma • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Ovarian Cancer • Pancreatic Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1